The Childhood Cancer Blog

The Childhood Cancer Blog

Welcome to The Childhood Cancer Blog
from Alex's Lemonade Stand Foundation!

Every donation to Alex's Lemonade Stand Foundation for childhood cancer helps researchers get closer to a cure for cancer.

 

by Trish Adkins, ALSF

Every time you make a donation for a cup of Alex’s Lemonade, you are moving researchers closer to breakthroughs. Since our beginnings, Alex’s Lemonade Stand Foundation has been dedicated to funding innovative, cutting-edge childhood cancer research. With your support, we’ve funded over 690 research grants since 2005!

Here are five researchers that you are helping to make breakthroughs, one cup... Read More

Better outcomes and cures for childhood leukemia will be found with continued genetic studies, innovation in technology and targeted treatments.

ALSF funded researchers like Dr. Todd Druley, pictured above, are closer than ever before to finding cures by studying DNA building blocks specific to childhood leukemia.​

by Trish Adkins

When a child is first diagnosed with leukemia, the goal is to force the disease into remission. The treatment protocol is long and grueling—at least 2 1/2 years of chemotherapy, lumbar punctures and clinic visits. Today, children diagnosed with the most common form of pediatric leukemia—acute lymphoblastic leukemia (ALL)—have a high cure rate. The discovery of genetic differences that can increase a child’s risk... Read More

Neuroblastoma, the type of cancer our founder Alex Scott battled, is the most-common extra-cranial solid tumor in childhood.  Alex’s Lemonade Stand Foundation (ALSF) has helped power research that is getting us closer to cures every day.

Neuroblastoma, the type of cancer our founder Alex Scott battled, is the most-common extra-cranial solid tumor in childhood. Alex’s Lemonade Stand Foundation (ALSF) has helped power research that is getting us closer to cures every day. Researchers like Dr. John Maris from the Children’s Hospital of Philadelphia (CHOP) and Dr. Katherine Matthay from the University of California San Francisco School of Medicine, who sit on the ALSF Scientific Advisory Board, are working to study what makes neuroblastoma tick — to... Read More

Pages